Exploring the association between ceramide, phosphatidylcholine, and COPD prevalence and incidence: a FINRISK population-based cohort study
These findings support the role of lipid biomarkers, particularly Cers and CERT scores, in improving COPD risk prediction and management, with potential implications for targeted interventions in smokers.
Authors
- Mika Hilvo (ORCID: https://orcid.org/0000-0003-0663-5843)
- A. Inkeri Lokki (ORCID: https://orcid.org/0000-0003-4397-8415)
- Mitja Lääperi (ORCID: https://orcid.org/0000-0003-0636-6567)
- Juha P. Sinisalo (ORCID: https://orcid.org/0000-0002-0169-5137)
- Mohammadreza Shoghli
- Marja‐Liisa Lokki (ORCID: https://orcid.org/0000-0002-4159-4293)
- Reijo Laaksonen (ORCID: https://orcid.org/0000-0001-9888-4278)
- Jaakko Tuomilehto (ORCID: https://orcid.org/0000-0002-3424-0745)
- Antti Jylhä (ORCID: https://orcid.org/0000-0002-9910-1017)
Institutions
- University of Helsinki (FI)
- Tampere University of Applied Sciences (FI)
- Helsinki Institute of Physics (FI)
- Helsinki University Hospital (FI)
- Instituto de Salud Carlos III (ES)
- Finnish Institute for Health and Welfare (FI)
- Escuela Nacional de Sanidad (ES)
- Zora Biosciences (Finland) (FI)
- Tampere University (FI)
- VTT Technical Research Centre of Finland (FI)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1186/s12890-025-03884-7
- Primary Topic
- Sphingolipid Metabolism and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00